CTFG Launch Event: Cell Therapy Mini-Symposium
|
Date: 23 May 2018
Time: 12:15pm - 19:00pm (CTFG is open to public) Location : Creation Theatrette Matrix Building, Level 4 30 Biopolis Street Singapore 138671 |
Programme
|
Time |
|
|
11.30 – 12.15 |
SCSS AGM 2018 (Restricted to SCSS members
only!) |
|
12.15 – 13.00 |
Lunch Networking |
|
13.00– 13.15 |
Welcome & Introduction to CTFG
Launch Ray DUNN & John DANGERFIELD (Open to public) |
|
13.15-14.55 |
Session 1 (Chair: Shigeki SUGII, Singapore Bioimaging Consortium) |
|
13.15- 13.40 |
Glycosaminoglycans as Adjuvants for Enhanced Cellular Therapy Simon COOL, Institute of Medical
Biology, Singapore |
|
13.40 – 14.05 |
Growing and Using Blood Stem
Cells: Already a Reality William HWANG, Singapore General
Hospital |
|
14.05 – 14.30 |
A Co-operative Framework for
Encouraging Responsible Innovation with Autologous Cellular Therapies Tamra LYSAGHT, National University of Singapore |
|
14:30 – 14:55 |
The Next Generation of T Cell
Therapy to Tackle the Solid Tumor Challenge John CONNOLLY, TESSA Therapeutics,
Singapore |
|
14.55 – 15.30 |
Tea break |
|
15.30 – 16:45 |
Session 2 (Chair: John DANGERFIELD, AustriaNova, Singapore) |
|
15.30 – 15.55 |
TCR-T Cell Product Development
Strategy from Lab to Market Lietao Victor LI, Lion TCR, Singapore |
|
15.55 – 16.20 |
An Overview of Cell-based Therapy
in Malaysia Angela NG, Universiti Kebangsaan Malaysia
Medical Centre, Malaysia |
|
16.20 – 16.45 |
Clinical Outcomes of Mesenchymal
Stem Cell (MSC) Therapy for Cartilage Regeneration in Singapore James HUI, National University
Health System, Singapore |
|
16:45 – 16:50 |
Announcement: Duke-NUS, BioLamina and Novo Nordisk enter collaborative
research on stem cell-based therapy for heart and eye diseases Karl Tryggvason, Duke-NUS,
Singapore |
|
16:50 – 17:30 |
Panel Discussion Fostering Translational Research (Moderators: Tamra
LYSAGHT & Ray DUNN) Panel members: James Hui, Simon
Cool, John Connolly |
|
17.30 – 19:00 |
Wine & Dinner networking |